A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...

About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet far too many are being steered towards radical treatment ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

By comparison, prostate cancer figures are somewhat better, with about one-third of patients surviving beyond two years. Elsewhere in the world, these figures are nearly 100 per cent for prostate ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

It’s tough for a man to know what to do following a diagnosis of prostate cancer.The treatment is often worse than the ...

Prostate cancer is often seen as an unavoidable part of ageing, especially among men, but there are many myths that can ...